Optimal diuretic strategies in heart failure

被引:8
|
作者
Suri, Sarabjeet S. [1 ]
Pamboukian, Salpy V. [1 ]
机构
[1] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA
关键词
Heart failure (HF); diuresis; diuretic resistance; FUROSEMIDE; TOLVAPTAN;
D O I
10.21037/atm-20-4600
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heart failure (HF) is one of the major causes of morbidity and mortality in the world. According to a 2019 American Heart Association report, about 6.2 million American adults had HF between 2013 and 2016, being responsible for almost 1 million admissions. As the population ages, the prevalence of HF is anticipated to increase, with 8 million Americans projected to have HF by 2030, posing a significant public health and financial burden. Acute decompensated HF (ADHF) is a syndrome characterized by volume overload and inadequate cardiac output associated with symptoms including some combination of exertional shortness of breath, orthopnea, paroxysmal nocturnal dyspnea (PND), fatigue, tissue congestion (e.g., peripheral edema) and decreased mentation. The pathology is characterized by hemodynamic abnormalities that result in autonomic imbalance with an increase in sympathetic activity, withdrawal of vagal activity and neurohormonal activation (NA) resulting in increased plasma volume in the setting of decreased sodium excretion, increased water retention and in turn an elevation of filling pressures. These neurohormonal changes are adaptive mechanisms which in the short term are associated with increased contractility of the left ventricular (LV) and improvement in cardiac output. But chronically, the failing heart is unable to overcome the excessive pressure and volume leading to worsening HF. The primary symptomatic management of ADHF includes intravenous (IV) diuresis to help with decongestion and return to euvolemic status. Even though diuretics have not been shown to provide any mortality benefit, they have been clinically proven to be of significant benefit in the acute decompensated phase, as well as in chronic management of HF. Loop diuretics remain the mainstay of therapy for symptomatic management of HF with use of thiazide diuretics for synergistic effect in the setting of diuretic resistance. Poor diuretic efficacy has been linked with higher mortality and increased rehospitalizations.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Diuretic strategies in acute decompensated heart failure
    Lo, Kevin Bryan
    Nohria, Anju
    HEART FAILURE REVIEWS, 2025, 30 (02) : 417 - 430
  • [2] Treatment strategies for diuretic resistance in patients with heart failure
    Horiuchi, Yu
    Wettersten, Nicholas
    JOURNAL OF CARDIOLOGY, 2025, 85 (01) : 1 - 7
  • [3] Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure
    Cox, Zachary L.
    Hung, Rebecca
    Lenihan, Daniel J.
    Testani, Jeffrey M.
    JACC-HEART FAILURE, 2020, 8 (03) : 157 - 168
  • [4] Diuretic Strategies in Patients with Acute Decompensated Heart Failure
    Felker, G. Michael
    Lee, Kerry L.
    Bull, David A.
    Redfield, Margaret M.
    Stevenson, Lynne W.
    Goldsmith, Steven R.
    LeWinter, Martin M.
    Deswal, Anita
    Rouleau, Jean L.
    Ofili, Elizabeth O.
    Anstrom, Kevin J.
    Hernandez, Adrian F.
    McNulty, Steven E.
    Velazquez, Eric J.
    Kfoury, Abdallah G.
    Chen, Horng H.
    Givertz, Michael M.
    Semigran, Marc J.
    Bart, Bradley A.
    Mascette, Alice M.
    Braunwald, Eugene
    O'Connor, Christopher M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09) : 797 - 805
  • [5] Diuretic Potentiation Strategies in Acute Heart Failure
    Siddiqi, Tariq Jamal
    Packer, Milton
    Ezekowitz, Justin A.
    Fonarow, Gregg C.
    Greene, Stephen J.
    Kittleson, Michelle
    Khan, Muhammad Shahzeb
    Mentz, Robert J.
    Testani, Jeffrey
    Voors, Adriaan A.
    Butler, Javed
    JACC-HEART FAILURE, 2025, 13 (01) : 14 - 27
  • [6] Comparison of diuretic strategies in diuretic-resistant acute heart failure: a systematic review and network meta-analysis
    Orso, D.
    Tavazzi, G.
    Corradi, F.
    Mearelli, F.
    Federici, N.
    Peric, D.
    D'Andrea, N.
    Santori, G.
    Mojoli, F.
    Forfori, F.
    Vetrugno, L.
    Bove, T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2971 - 2980
  • [7] Diuretic therapy in congestive heart failure
    Kennelly, Patrick
    Sapkota, Rajju
    Azhar, Maimoona
    Cheema, Faisal Habib
    Conway, Claire
    Hameed, Aamir
    ACTA CARDIOLOGICA, 2022, 77 (02) : 97 - 104
  • [8] Diuretic Resistance Associated With Heart Failure
    Shams, Elham
    Bonnice, Sabrina
    Mayrovitz, Harvey N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [9] A 2018 overview of diuretic resistance in heart failure
    Jardim, Sofia Isabel
    dos Santos, Luis Ramos
    Araujo, Ines
    Marques, Filipa
    Branco, Patricia
    Gaspar, Augusta
    Fonseca, Candida
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2018, 37 (11) : 935 - 945
  • [10] Diuretic Treatment in Heart Failure
    Ellison, David H.
    Felker, G. Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) : 1964 - 1975